Info

Hai inserito l'indirizzo di un sito  Kleresca® al di fuori del tuo paese. Ricorda che le informazioni sul sito potrebbero non essere valide per il tuo paese.

Creation or Destruction?

Which would you choose for your skin? For us, the choice is easy. 
If you had a choice between breaking down or building up your skin, which would you choose? We think we know the answer. Dealing with rosacea often means dealing with sensitive skin, and the last thing sensitive skin wants is a harsh product or procedure.
This reality can be tough because a lot of treatments available can be painful, may require some sort of prescription drug, or simply don’t work for you. 
One of the best parts of Kleresca® Rosacea Treatment is it works to improve microvascularisation, which is basically the creation of more blood vessels. If you’re thinking, “Hmm yeah, that’s the last thing I want from a rosacea treatment”, hear us out:
 

Improving microvascularisation creates more fine blood vessels. More vessels equal better blood flow. More blood flow equals less visible blood vessels. So, what does that mean for your skin? Well, a few things:

1. Reduced redness and flushing
2. Less burning and stinging 
3. Overall, less stress in your skin

At Kleresca® we don’t believe in destruction. What we do believe in is building up your skin’s own repair mechanisms through fluorescent light energy and ensuring our treatment is suitable for highly sensitive skin. Our ultimate goal? Helping you feel good about your skin. And how do we do that? No cell destruction, and no painful shortcuts.

 

Follow us on our social media channels to stay up to date with our latest news, real-life results stories, and breakthrough scientific advancements in treating skin. 

      
        


 




Sources

Braun, S.A.& Gerber, P. A photoconverter -gel assisted blue light therapy for the treatment of rosacea. Int. K Dermatol. 2017 [Epub ahead of print]
Nielsen, Schoedt & Bak-Christensen. Clinical Evaluation – Kleresca® Biophotonic Treatments. 2017. Kleresca® Data on File
J. Spoendlin, J. J. Voegel, S. S. Jick, C. R. Meier. (2012, September). A study on the epidemiology of rosacea in the U.K. British Journal of Dermatology, 167(3), 598-605.
National Rosacea Society. (2018). Rosacea Now Estimated to Affect at Least 16 Million Americans. Retrieved January 31, 2018, from www.rosacea.org: https://www.rosacea.org/rr/2010/winter/article_1.php 
 

Is Early Diagnosis of Rosacea Really That Important?

Understanding your body is powerful. So, when your skin gives you a sign that something is not right, you should listen.

Kleresca® utilizza cookie per assicurarti la migliore esperienza online e fornirti dati relativi all’uso del sito in forma anonima e aggregata. Cliccando ’Sì, acconsento’, acconsenti a questo utilizzo dei cookie. Puoi scoprire quali cookie usiamo, come funzionano e come disabilitarli, nella nostra Politica dei Cookie. Puoi inoltre trovare maggiori informazioni al riguardo nella nostra Informativa sulla Privacy

Questa pagina web contiene materiale promozionale secondo la legislazione vigente in materia di pubblicità sulla salute.